Guidance For Industry Investigator Responsibilities – Protecting The Rights, Safety, And Welfare Of Study Subjects
Contains Nonbinding Recommendations
TABLE OF CONTENTS
I. INTRODUCTION
II. OVERVIEW OF INVESTIGATOR RESPONSIBILITIES
III. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES
A. Supervision of the Conduct of a Clinical Investigation
1. What Is Appropriate Delegation of Study-Related Tasks?
2. What Is Adequate Training?
3. What Is Adequate Supervision of the Conduct of an Ongoing Clinical Trial?
4. What Are an Investigator’s Responsibilities for Oversight of Other Parties Involved in the Conduct of a Clinical Trial?
B. Protecting the Rights, Safety, and Welfare of Study Subjects
1. Reasonable Medical Care Necessitated by Participation in a Clinical Trial.
2. Reasonable Access to Medical Care.
3. Protocol Violations that Present Unreasonable Risks.
ATTACHMENT A: COPY OF FORM 1572.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Additional copies are available from:
Office of Training and Communication
Division of Drug Information, HFD-240
Center for Drug Evaluation and Research
Food and Drug Administration
(Tel) 301-827-4573
http://www.fda.gov/cder/guidance/index.htm or
Office of Communication, Training and Manufacturers Assistance, HFM-40
Center for Biologics Evaluation and Research
Food and Drug Administration
http://www.fda.gov/cber/guidelines.htm (Tel) 800-835-4709 or 301-827-1800 or
Office of Health and Industry Programs
Division of Small Manufacturers, International, and Consumer Assistance, HFZ-220
Center for Devices and Radiological Health
Food and Drug Administration
Tel: 1-800-638-2041
http://www.fda.gov/cdrh U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Procedural
October 2009
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Nadchodzące badania kliniczne
-
National Institute of Medical Sciences and Nutrition...Jeszcze nie rekrutacjaRhA – reumatoidalne zapalenie stawów
-
Institute of Liver and Biliary Sciences, IndiaJeszcze nie rekrutacjaOstra-przewlekła niewydolność wątrobyIndie
-
Centre Leon BerardJeszcze nie rekrutacjaRak żołądka | Rak połączenia przełykowo-żołądkowegoFrancja
-
TC Erciyes UniversityRekrutacyjnyChoroba endodontycznaIndyk
-
Casa di Cura Privata 'Malzoni - Villa dei Platani...Rekrutacyjny
-
Assembly BiosciencesJeszcze nie rekrutacjaNawracająca opryszczka narządów płciowych typu 2Nowa Zelandia
-
Cerenovus, Part of DePuy Synthes Products, Inc.Jeszcze nie rekrutacjaOstry udar niedokrwiennyStany Zjednoczone
-
Pamukkale UniversityJeszcze nie rekrutacjaPęcherz moczowy, nadczynnośćIndyk
-
China-Japan Friendship HospitalJeszcze nie rekrutacjaOtyłość | Cukrzyca | Kamienie żółciowe | Zastój żółciowy
-
AstraZenecaDaiichi SankyoJeszcze nie rekrutacjaRak piersi z przerzutami | HER2-dodatni rak piersi | Nieoperacyjny rak piersi | Rak piersi z ekspresją HER2-lowKanada
-
Chinese University of Hong KongRekrutacyjny
-
Central Hospital, Nancy, FranceJeszcze nie rekrutacja